Improving survival following AIDS in Australia, 1991-1996

AIDS

Volumn 14, Issue 15, 2000, Pages 2349-2354

  Li, Y ^a   McDonald, A M ^a   Dore, G J ^a   Kaldor, J M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

AIDS surveillance; AIDS defining illness; Australia; Late presentation; Survivial following AIDS

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; AUSTRALIA; BRAIN INFECTION; CLINICAL FEATURE; CONSULTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHODGKIN LYMPHOMA; ONSET AGE; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AUSTRALIA; DISEASE NOTIFICATION; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; STATISTICS, NONPARAMETRIC;

EID: 0033768520     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200010200-00016     Document Type: Article

References (23)

1. Update trends in AIDS incidence, deaths, and prevalence United States, 1996
2. Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection
3. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study
4. Impact of protease inhibitors on AIDS defining events and hospitalizations in 10 French AIDS reference centres
5. Decline in deaths from AIDS due to new antiretrovirals
6. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality
7. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
8. Increasing survival time after AIDS in Italy: The role of new combination antiretroviral therapies
9. Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998
10. The role of initial AIDS-defining illness in survival following AIDS
11. The acquired immunodeficiency syndrome in Australia: Incidence 1982-1991
12. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
13. Definition of HIV infection and AIDS defining illnesses
14. Regression models and life tables
15. Risk of cancer in people with AIDS
16. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis
17. Delta: A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
18. Randomised trial of addition of lamivudine or lamivudine plus Ioviride to zidovudine-containing regimens for patients with HIV-1 infection: The CAESAR trial
19. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter
20. Factors influencing survival after AIDS: Report from the multicenter AIDS cohort study (MACS)
21. Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study